Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
LGBT+ health adviser urges Britain to make HIV-prevention drug free

Britain’s first national adviser for LGBT+ health has said the roll-out of a highly effective HIV prevention pill could save hundreds of thousands of pounds for the country’s publicly funded health authority. In an exclusive interview Michael Brady, who will take up the role on April 1, said a planned roll-out of pre-exposure prophylaxis (PrEP) - a once-daily pill that protects against HIV – in England would prove cost effective “very quickly”.

Published
18 March 2019
From
Reuters
Obituary: Mags Portman died on February 6th

The sexual-health pioneer and campaigner for access to PrEP was 44

Published
15 March 2019
From
The Economist (requires free registration)
Jean-Michel Molina, MD, on Biomedical Failures of PrEP: Rare, But Serious

"There are multiple reasons for PrEP failures and they could be at any point in the PrEP continuum of care. From people who may not use their pills as recommended, to a health care system that is not able to provide access to PrEP for people in need, it could be also the physicians who are not ready to prescribe PrEP or not aware that they could use PrEP for preventing HIV in high-risk patients. It could be also the test that we use sometimes that are not able to detect acute HIV infection. And, if you start PrEP in someone with acute HIV infection you will see more resistance."

Published
14 March 2019
From
Contagion Live
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle.

Published
14 March 2019
From
The New York Times
Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Gilead Sciences has the data it’ll need to start transitioning patients taking Truvada for PrEP over to Descovy, a drug with a longer patient life. But once Truvada generics hit, it might be a different story.

Published
14 March 2019
From
FiercePharma
Young Black Men at Risk for HIV Underestimate Threat

A study that started out looking at HIV risk behaviors and substance use turned into an opportunity for researchers to examine what it would take for young black men who have sex with men to try pre-exposure prophylaxis (PrEP) and stay on it.

Published
12 March 2019
From
Medscape (requires free registration)
Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

The London mayor said: “I’m shocked that the Government is failing to provide local authorities in London with the funding they need to provide PrEP to all those who could benefit.”

Published
12 March 2019
From
Evening Standard
How Many More Must Needlessly Contract HIV Before We Ensure Proper Access To PrEP?

Local authorities are legally responsible for providing information and services that can help prevent HIV. We are calling on local authorities in London to urgently double the number of places offered to them as part of the trial. Other parts of England have shown decisive leadership on PrEP access, it’s time for London to do the same.

Published
12 March 2019
From
Huffington Post
Effective HIV Interventions Have Changed the Approach to Trials

In the past, individuals who were at high risk for HIV infection and who were enrolled in placebo-controlled prevention trials had been typically randomly assigned to either an experimental agent or placebo. However, that trial design—and the way those trials were interpreted—has shifted. This was the topic of discussion during David Dunn’s session yesterday at the Conference on Retroviruses and Opportunistic Infections (CROI) 2019. Dunn is a researcher at University College London in the United Kingdom.

Published
11 March 2019
From
Infectious Diseases Consultant
PrEP use jumps to 35 percent among gay and bi men at risk of HIV

A third of gay and bisexual men use PrEP for HIV prevention, and nine in 10 are aware of it, but the CDC says the drug is still underused.

Published
08 March 2019
From
NBCNews.com
← First12345...123Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.